# ConcertAI Expands CancerLinQ Suite with AI-Driven Trial Matching at ASCO 2026

> partnership · REPORTED · 2026-07-01

ConcertAI unveiled major enhancements to its CancerLinQ Suite at the 2026 ASCO Annual Meeting, adding AI-driven clinical trial matching and contextualized patient insights to give oncologists faster decision support within existing clinical workflows.

About ConcertAI: ConcertAI is a real-world healthcare intelligence company providing AI-powered data analytics, clinical trial optimization, and oncology insights to biopharma companies and healthcare providers.

- Company: ConcertAI
- Sector: digital health
- Primary source: https://www.healthcarenowradio.com/health-it-product-news-report-july-2026/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.